Teva Pharmaceutical Industries (TEVA) Selling, General & Administrative (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded Selling, General & Administrative of $317 million in Q2 2026, up 3.9% from $305 million a year earlier and up 4.3% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Selling, General & Administrative (2009 - 2026) Analysis & Trends
On a TTM basis, Teva Pharmaceutical Industries' Selling, General & Administrative came in at $1.31 billion as of Jun 30, 2026, up 8.6% year-over-year; for FY2025, it came in at $1.29 billion, up 10.9% from FY2024.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $1.16 billion in FY2024 (-0.1%), $1.16 billion in FY2023 (-1.5%), $1.18 billion in FY2022 (+7.4%) and $1.1 billion in FY2021 (-6.3%).
- Quarterly Selling, General & Administrative has ranged from $268 million in Q3 2023 to $367 million in Q4 2025 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has increased for eight consecutive quarters, with growth averaging 7.9% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 29.3% in Q2 2022, against a decline of 15.3% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $304 million (Q1 2026), $367 million (Q4 2025) and $317 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn | 317.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 317.00 Mn |
| Mar 31, 2026 | 304.00 Mn |
| Dec 31, 2025 | 367.00 Mn |
| Sep 30, 2025 | 317.00 Mn |
| Jun 30, 2025 | 305.00 Mn |
| Mar 31, 2025 | 297.00 Mn |
| Dec 31, 2024 | 302.00 Mn |
| Sep 30, 2024 | 298.00 Mn |
| Jun 30, 2024 | 283.00 Mn |
| Mar 31, 2024 | 278.00 Mn |
| Dec 31, 2023 | 292.00 Mn |
| Sep 30, 2023 | 268.00 Mn |
| Jun 30, 2023 | 307.00 Mn |
| Mar 31, 2023 | 296.00 Mn |
| Dec 31, 2022 | 288.00 Mn |
| Sep 30, 2022 | 283.00 Mn |
| Jun 30, 2022 | 313.00 Mn |
| Mar 31, 2022 | 296.00 Mn |
| Dec 31, 2021 | 277.00 Mn |
| Sep 30, 2021 | 291.00 Mn |
API Access
Teva Pharmaceutical Industries Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();